Xxxxxxxxx, C. A. No. 2017-0163-JTL (Del. Ch.) (the “225 Action”), Immunomedics will seek Court approval of such agreed fees and expenses, or (ii) if the Status Quo Order is no longer in effect, Immunomedics and venBio will advise the Court that they have reached an agreement with respect to such fees and expenses, and Immunomedics will provide notice of such agreement through a Form 8-K filing. Seattle Genetics will take no position on any of these issues.
Xxxxxxxxx, C. A. No. 2020- 0655-JTL (Del. Ch.), Xxxxxx x.
Xxxxxxxxx, C. A. No. 2021-1001-PAF (Del. Ch.)
Xxxxxxxxx, C. A. No. 2021-1001-PAF (Del. Ch.), and any action(s) involving substantially similar claims (the “Actions”). Pursuant to an Order of the United States District Court for the Northern District of Texas, a hearing will be held on [____], at [ ], before the Xxxxxxxxx Xxxxxxxx Xxxxx at 0000 Xxxxxxxx Xxxxxx, Xxxxxxxxx 0000, Xxxxxx, XX 00000 to consider whether judgment should be entered: (1) approving the terms of the Settlement as fair, reasonable, adequate, and in the best interests of Fluor and its stockholders; (ii) dismissing with prejudice the Released Claims pursuant to the terms of the Stipulation; and (iii) ruling upon Texas Federal Court Lead Plaintiffs' Counsel’s request for approval of the agreed Fee and Expense Amount. If you are a holder of Fluor Corp. common stock, your rights may be affected by these lawsuits and the settlement thereof. The Stipulation and Notice for the Settlement may be viewed at xxx.xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.xxx. The Notice contains details about this Action and Settlement, including what you must do to object to the Settlement. Objections must be filed with the Court by [ ], and the Settlement Hearing is scheduled for [___ ]. If you have questions about this Settlement, you may contact Texas Federal Court Lead Plaintiffs’ Counsel at the following addresses: Xxxxx X. Xxxxxxx Xxxxxxx LLP, 0000 Xxxxxxxx Xxxxx, Xxxxx 000, Xxx Xxxxx, XX 0000 -OR- Xxxxxxxx X. Xxxxxxx Xxxxx+Xxxxx Attorneys at Law, 00000 Xxxxx Xxxx, Xxxxx 00, Xxxxxxxxx Xxxxxxx, XX 00000. DATED: [____ ], 2023 P.O. Box XXXX CITY, STATE ZIP FIRST-CLASS MAIL U.S. POSTAGE PAID Portland, OR PERMIT NO. 2882 <<MAIL ID>> <<NAME 1>> <<NAME 2>> <<ADDRESS LINE 1>> <<ADDRESS LINE 2>> <<ADDRESS LINE 3>> <<ADDRESS LINE 4>> <<ADDRESS LINE 5>> <<CITY, STATE ZIP>> <<COUNTRY>>
Xxxxxxxxx, C. A. No. 2022-0057-PAF (Del. Ch.), Xxxxxx x.
Xxxxxxxxx, C. Murrxx Xxxxx
Xxxxxxxxx, C. Paris, S.: Direct trajectory optimization using nonlinear pro- gramming and collocation. XXXX X. Xxxxxxxx 10, 338–342 (1987)
Xxxxxxxxx, C. A. No. 2021-1001-PAF (Del. Ch.), and any action(s) involving substantially similar claims (together, the “Actions”). If the Court approves the proposed Settlement, you, Fluor Corporation (“Fluor” or the “Company”), and all Current Fluor Stockholders will be forever barred from contesting the fairness, adequacy, and reasonableness of the proposed Settlement and from pursuing the Released Stockholder Claims. All capitalized terms used in this Notice that are not otherwise defined herein have the meanings provided in the Stipulation and Agreement of Settlement entered into on [__ __], 2023 (“Stipulation”), by and among the following: (1) Xxx Xxx and Xxxx Xxxxxxx (collectively, the “ Texas Federal Court Lead Plaintiffs”); (2) Xxxxxx Xxxxxxx, Xxxx Xxxxxxx, Xxxxx Xxxx, Xxxxx Xxx, Xxxxxx Xxxxxx, Xx., Xxxxxxx Xxx, Xxxxx Xxxxxxxx, Xxxxxx Xxxxx, Xxxxx Xxxxxxxx, Xxxxxxxx Xxxxx, and Xxxxx Xxxxxx (collectively and together with Texas Federal Court Lead Plaintiffs, the “Plaintiffs”); (3) current and former officers of Fluor and members of the Board of Directors of Fluor (the “Board”): Xxxx Xxxxxxxxx, Xxxxx X. Xxxxx, Xxxxxxxx X. Xxxxxxx, Xxxx X. Xxxxxxx, Xxxxxxx X. Xxxxxxx, Xxxxxxx X. Xxxx, Xxxxx X. Xxxxxxx, Xxxxx X. Xxxxxxxxx, Xxxxxx X. Xxxxxxx, Xxxxx X. Xxxxxx, Xxxxxx X. Xxxxxxxxx, Xxxxx X. Xxxxxx, Xxxxxxx X. XxXxxxxxx, Xxxxx X. Xxxxxx, Xxxxxx X. Xxxxxxx, Xxxx X. Xxxxx, Xxxxxx X. Xxxxxxxx XXX, Xxxxx X. Xxxxxxx, Xxxxxxx XxXxxxxx, Xxxx X. Xxxxxxx, X. Xxxxxxx Xxxxxxx, Xxxxx X. Xxxxxx, Xxxxxx Xxxxxxx, Xxxxx X. Xxxxxx, and The Estate of Xxxx X. X’Xxxx (collectively, the “Individual Defendants”); and (4) nominal defendant Fluor (together with the Individual Defendants, the “Defendants”). Plaintiffs and Defendants are collectively referred to herein as the “Parties.” AND RELEASES. You can obtain more information by reviewing the Stipulation, which is available at xxx.xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.xxx.
Xxxxxxxxx, C. A. No. 2021- 1001-PAF (Del. Ch.), and any action(s) involving substantially similar claims (together, the “Actions”). If the Court approves the proposed Settlement, you, Fluor Corporation (“Fluor” or the “Company”), and all Current Fluor Stockholders will be forever barred from contesting the fairness, adequacy, and reasonableness of the proposed Settlement and from pursuing the Released Stockholder Claims. $2,400,000 in attorneys’ fees and reimbursement of expenses, subject to approval by the Court.
Xxxxxxxxx, C. Xxxxxxxx and X. X. Xxxxxxxxx (eds.), Universals of Human Language: III: Word Structure,
